Propanc Biopharma Stock Price History

PPCB Stock  USD 0.0003  0.00  0.00%   
If you're considering investing in Propanc Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Propanc Biopharma stands at 0.0003, as last reported on the 13th of January 2025, with the highest price reaching 0.0003 and the lowest price hitting 0.0003 during the day. Propanc Biopharma is out of control given 3 months investment horizon. Propanc Biopharma maintains Sharpe Ratio (i.e., Efficiency) of 0.0928, which implies the firm had a 0.0928% return per unit of risk over the last 3 months. We were able to break down twenty-four different technical indicators, which can help you to evaluate if expected returns of 2.05% are justified by taking the suggested risk. Use Propanc Biopharma Risk Adjusted Performance of 0.0707, coefficient of variation of 1345.35, and Semi Deviation of 12.48 to evaluate company specific risk that cannot be diversified away.
  
Propanc Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0928

Best PortfolioBest Equity
Good Returns
Average ReturnsPPCB
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 22.08
  actual daily
96
96% of assets are less volatile

Expected Return

 2.05
  actual daily
40
60% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
7
93% of assets perform better
Based on monthly moving average Propanc Biopharma is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Propanc Biopharma by adding it to a well-diversified portfolio.

Propanc Biopharma Pink Sheet Price History Chart

There are several ways to analyze Propanc Stock price data. The simplest method is using a basic Propanc candlestick price chart, which shows Propanc Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 18, 20244.0E-4
Lowest PriceDecember 10, 20242.0E-4

Propanc Biopharma January 13, 2025 Pink Sheet Price Synopsis

Various analyses of Propanc Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Propanc Pink Sheet. It can be used to describe the percentage change in the price of Propanc Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Propanc Pink Sheet.
Propanc Biopharma Price Rate Of Daily Change 1.00 

Propanc Biopharma January 13, 2025 Pink Sheet Price Analysis

When benchmark price declines in a down market, there may be an uptick in Propanc Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Propanc Biopharma intraday prices and daily technical indicators to check the level of noise trading in Propanc Stock and then apply it to test your longer-term investment strategies against Propanc.

Propanc Pink Sheet Price History Data

The price series of Propanc Biopharma for the period between Tue, Oct 15, 2024 and Mon, Jan 13, 2025 has a statistical range of 0.0 with a coefficient of variation of 20.42. The price distribution for the period has arithmetic mean of 0.0. The median price for the last 90 days is 0.0. The company completed stock split (1:1000) on 19th of November 2020. Propanc Biopharma had dividends distributed to its stock-holders on 2020-11-19.
OpenHighLowCloseVolume
01/13/2025
 0.0003  0.0003  0.0003  0.0003 
01/10/2025 0.0003  0.0003  0.0003  0.0003  453,400 
01/08/2025 0.0003  0.0003  0.0003  0.0003  600,900 
01/07/2025 0.0003  0.0003  0.0003  0.0003  915,000 
01/06/2025 0.0003  0.0004  0.0002  0.0003  12,000,800 
01/03/2025 0.0004  0.0004  0.0003  0.0004  19,478,400 
01/02/2025 0.0003  0.0004  0.0002  0.0004  132,352,100 
12/31/2024 0.0002  0.0002  0.0002  0.0002  5,000,000 
12/30/2024 0.0003  0.0003  0.0002  0.0002  13,154,100 
12/27/2024 0.0002  0.0002  0.0002  0.0002  5,000,000 
12/26/2024 0.0002  0.0003  0.0002  0.0002  5,142,500 
12/24/2024 0.0002  0.0003  0.0002  0.0002  13,620,100 
12/23/2024 0.0002  0.0003  0.0002  0.0003  6,552,900 
12/20/2024 0.0003  0.0003  0.0002  0.0002  928,400 
12/19/2024 0.0003  0.0003  0.0003  0.0003  2,310,500 
12/18/2024 0.0003  0.0003  0.0002  0.0003  3,691,500 
12/17/2024 0.0002  0.0003  0.0002  0.0003  14,119,200 
12/16/2024 0.0003  0.0003  0.0002  0.0003  699,400 
12/13/2024 0.0003  0.0003  0.0002  0.0002  1,133,834 
12/12/2024 0.0002  0.0003  0.0002  0.0003  8,815,432 
12/11/2024 0.0002  0.0003  0.0002  0.0002  5,215,900 
12/10/2024 0.0003  0.0003  0.0002  0.0002  3,502,500 
12/09/2024 0.0003  0.0003  0.0003  0.0003  279,025 
12/06/2024 0.0002  0.0003  0.0002  0.0003  799,100 
12/05/2024 0.0003  0.0003  0.0003  0.0003  289,900 
12/04/2024 0.0002  0.0003  0.0002  0.0003  4,891,200 
12/03/2024 0.0003  0.0003  0.0003  0.0003  2,772,900 
12/02/2024 0.0004  0.0004  0.0002  0.0003  4,147,800 
11/29/2024 0.0003  0.0003  0.0002  0.0003  1,564,600 
11/27/2024 0.0003  0.0003  0.0002  0.0003  7,241,700 
11/26/2024 0.0003  0.0003  0.0003  0.0003  3,682,900 
11/25/2024 0.0003  0.0004  0.0003  0.0003  5,020,229 
11/22/2024 0.0003  0.0003  0.0003  0.0003  9,276,800 
11/21/2024 0.0004  0.0004  0.0003  0.0003  2,769,200 
11/20/2024 0.0003  0.0003  0.0003  0.0003  2,500,000 
11/19/2024 0.0003  0.0003  0.0003  0.0003  1,551,153 
11/18/2024 0.0003  0.0004  0.0003  0.0003  2,126,600 
11/15/2024 0.0003  0.0004  0.0003  0.0003  1,414,999 
11/14/2024 0.0003  0.0004  0.0003  0.0003  2,958,430 
11/13/2024 0.0003  0.0004  0.0003  0.0004  2,538,600 
11/12/2024 0.0004  0.0004  0.0003  0.0004  447,200 
11/11/2024 0.0003  0.0004  0.0002  0.0004  56,500 
11/08/2024 0.0004  0.0004  0.0004  0.0004  539,700 
11/07/2024 0.0003  0.0004  0.0003  0.0004  6,962,800 
11/06/2024 0.0003  0.0004  0.0003  0.0004  7,493,800 
11/05/2024 0.0003  0.0004  0.0003  0.0004  7,816,844 
11/04/2024 0.0003  0.0004  0.0003  0.0003  5,280,996 
11/01/2024 0.0003  0.0003  0.0003  0.0003  8,517,900 
10/31/2024 0.0003  0.0003  0.0003  0.0003  6,450,600 
10/30/2024 0.0003  0.0004  0.0003  0.0003  8,348,421 
10/29/2024 0.0004  0.0004  0.0003  0.0004  2,576,700 
10/28/2024 0.0004  0.0004  0.0003  0.0004  4,885,400 
10/25/2024 0.0003  0.0004  0.0003  0.0004  4,176,450 
10/24/2024 0.0003  0.0003  0.0003  0.0003  5,369,200 
10/23/2024 0.0004  0.0004  0.0003  0.0004  3,550,200 
10/22/2024 0.0003  0.0004  0.0003  0.0004  20,102,900 
10/21/2024 0.0003  0.0004  0.0003  0.0003  6,031,581 
10/18/2024 0.0003  0.0004  0.0003  0.0004  5,009,944 
10/17/2024 0.0003  0.0003  0.0003  0.0003  10,400,000 
10/16/2024 0.0004  0.0004  0.0003  0.0003  420,000 
10/15/2024 0.0004  0.0004  0.0003  0.0003  1,190,200 

About Propanc Biopharma Pink Sheet history

Propanc Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Propanc is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Propanc Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Propanc Biopharma stock prices may prove useful in developing a viable investing in Propanc Biopharma
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia. Propanc Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.

Propanc Biopharma Pink Sheet Technical Analysis

Propanc Biopharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Propanc Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Propanc Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run My Watchlist Analysis Now

   

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch Module

Propanc Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Propanc Biopharma's price direction in advance. Along with the technical and fundamental analysis of Propanc Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Propanc to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Propanc Pink Sheet analysis

When running Propanc Biopharma's price analysis, check to measure Propanc Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Propanc Biopharma is operating at the current time. Most of Propanc Biopharma's value examination focuses on studying past and present price action to predict the probability of Propanc Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Propanc Biopharma's price. Additionally, you may evaluate how the addition of Propanc Biopharma to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stocks Directory
Find actively traded stocks across global markets